Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Cornell researchers are demonstrating how artificial intelligence—particularly deep learning and generative modeling—can ...

SINGAPORE] Imagine a world where life-saving treatments are discovered not in decades, but in just a few years. Nanyang ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

The $2M Millennium M2000 Supercomputer from Cadence and NVIDIA reshapes chip, drug, and AI design with Blackwell-powered ...

This synergy enables AI-driven breakthroughs, making simulations faster, more scalable, and more energy-efficient across ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The artificial intelligence (AI) revolution is reshaping our world at an unprecedented pace. As AI technology evolves, it's ...